Liminatus Pharma - Warrants (LIMNW) closed at $0.04 on November 13, 2026, unchanged from the previous close, on volume of 1 shares (30-day average 202).
Data as of November 13, 2026.
No headlines found.
No press releases found.
No news found.
Liminatus Pharma - Warrants trades on the stock market under the symbol LIMNW.
As of November 16, 2026, LIMNW stock price was flat at $0.04 with million shares trading.
LIMNW has a market cap of $0.00. This is considered a Sub-Micro Cap stock.
LIMNW has underperformed the market in the last year with a return of -64.6%, while the SPY ETF gained +11.9%. In the last 3 month period, LIMNW fell short of the market, returning -31.0%, while SPY returned -4.1%. However, in the most recent 2 weeks LIMNW has outperformed the stock market by returning 0.0%, while SPY returned -1.5%.
LIMNW support price is $.04 and resistance is $.04 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that LIMNW shares will trade within this expected range on the day.